|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.50 USD | +0.96% |
|
+10.96% | -42.11% |
| Dec. 11 | Baird Adjusts Price Target on Molina Healthcare to $146 From $179, Maintains Neutral Rating | MT |
| Nov. 24 | US health insurers buoyed by prospect of extended Obamacare subsidies |  |
| Capitalization | 8.66B 7.38B 6.89B 6.48B 11.94B 784B 13.04B 80.45B 31.2B 370B 32.5B 31.81B 1,349B | P/E ratio 2025 * |
14.2x | P/E ratio 2026 * | 14x |
|---|---|---|---|---|---|
| Enterprise value | 7.82B 6.66B 6.22B 5.86B 10.78B 708B 11.78B 72.65B 28.18B 334B 29.35B 28.73B 1,218B | EV / Sales 2025 * |
0.17x | EV / Sales 2026 * | 0.16x |
| Free-Float |
99.89% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Molina Healthcare, Inc.
| 1 day | -1.70% | ||
| 1 week | +10.96% | ||
| Current month | +13.65% | ||
| 1 month | +19.48% | ||
| 3 months | -6.84% | ||
| 6 months | -42.59% | ||
| Current year | -42.11% |
| 1 week | 151.86 |  | 171.81 |
| 1 month | 133.4 | | 171.81 |
| Current year | 133.4 | | 359.97 |
| 1 year | 133.4 | | 359.97 |
| 3 years | 133.4 | | 423.92 |
| 5 years | 133.4 | | 423.92 |
| 10 years | 42.56 | | 423.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Zubretsky
CEO | Chief Executive Officer | 68 | 2017-11-05 |
Mark Keim
DFI | Director of Finance/CFO | 59 | 2021-02-16 |
Jason Dees
CTO | Chief Tech/Sci/R&D Officer | - | 2020-01-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Ronna Romney
BRD | Director/Board Member | 81 | 1998-12-31 |
Steven Orlando
BRD | Director/Board Member | 73 | 2005-11-03 |
Dale Wolf
CHM | Chairman | 71 | 2017-05-01 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.6% | 5 M€ | 0.00% | - |
| 1.82% | 2 M€ | +9.31% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.96% | +10.96% | -43.30% | -52.27% | 8.66B | |
| +1.52% | +3.30% | -33.72% | -37.38% | 310B | |
| -0.32% | +8.56% | -5.11% | -32.78% | 79.8B | |
| +0.90% | +3.49% | -2.92% | -19.04% | 73.38B | |
| +0.74% | +4.11% | -1.59% | -49.35% | 32.29B | |
| +0.96% | +6.55% | -29.57% | -52.99% | 20.08B | |
| -0.26% | -0.97% | +74.10% | +61.47% | 3.87B | |
| +2.69% | +11.20% | +79.74% | -14.42% | 2.3B | |
| -1.82% | +4.65% | -10.00% | +143.24% | 1.4B | |
| -2.25% | -0.17% | -22.99% | - | 385M | |
| Average | -0.13% | +5.17% | +0.47% | -5.95% | 53.18B | |
| Weighted average by Cap. | +0.02% | +4.42% | -21.88% | -34.42% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 44.93B 38.28B 35.75B 33.64B 61.93B 4,070B 67.66B 417B 162B 1,918B 169B 165B 6,999B | 46.99B 40.03B 37.39B 35.18B 64.77B 4,256B 70.76B 436B 169B 2,006B 176B 173B 7,320B |
| Net income | 631M 537M 502M 472M 869M 57.13B 950M 5.86B 2.27B 26.93B 2.37B 2.32B 98.24B | 601M 512M 478M 450M 828M 54.4B 905M 5.58B 2.16B 25.64B 2.25B 2.21B 93.56B |
| Net Debt | -840M -715M -668M -629M -1.16B -76.05B -1.26B -7.8B -3.03B -35.85B -3.15B -3.08B -131B | -1.23B -1.05B -980M -922M -1.7B -112B -1.85B -11.44B -4.44B -52.57B -4.62B -4.52B -192B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 168.50 $ | +0.96% | 1,780,596 |
| 25-12-11 | 166.90 $ | +3.97% | 1,533,331 |
| 25-12-10 | 160.52 $ | +2.32% | 1,174,398 |
| 25-12-09 | 156.88 $ | +0.88% | 1,373,975 |
| 25-12-08 | 155.51 $ | +2.40% | 1,898,670 |
Delayed Quote Nyse, December 12, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MOH Stock
Select your edition
All financial news and data tailored to specific country editions
